avanafil

"This is the second Phase 3 study in which avanafil demonstrated efficacy, fast onset-of-action and was well tolerated," said Vivus Chief Executive

Vivus Says Phase-3 Test Results Positive for ED Treatment 2010

Inc. announced positive results from a late-stage study of its drug avanafil, designed to treat erectile dysfunction in men with type-1 and type-2 diabetes.

Vivus Says Phase-3 Test Results Positive for ED Treatment 2010

It owns the worldwide rights to avanafil except in some Asian Pacific Rim countries.

SFGate: Top News Stories 2011

Drug developer Vivus Inc. said Thursday the Food and Drug Administration will make a decision in its impotence drug candidate avanafil by April 29, 2012.

SFGate: Top News Stories 2011

Phase 3 pivotal REVIVE study data of VIVUS 'avanafil for ED presented at

THE MEDICAL NEWS 2010

Phase 3 pivotal REVIVE study data of VIVUS 'avanafil for ED presented at 2010 AUA

THE MEDICAL NEWS 2010

In the area of sexual health, VIVUS is in phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction.

The Earth Times Online Newspaper 2010

New data from phase 3 study of avanafil for treatment of ED announced

THE MEDICAL NEWS Editors 2010

ARNA's several Phase I candidates include a partnership with Ortho-McNeil-Janssen Pharmaceuticals, Inc. for diabetes, and VVUS's avanafil, an erectile dysfunction candidate in Phase III studies, shows promise as effective in only 15 minutes with so few side effects that it may be safe for patients using nitrates for chest pain.

SeekingAlpha.com: Home Page Ruthanne Williams Roussel 2010

Luramist, will be returned to FemPharm, and Vivus will refocus its efforts on two other drugs in the pipeline: Qnexa for obesity and avanafil for erectile dysfunction.

BloggingStocks Elizabeth Harrow 2010